Philip E. Lapinski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Research Interests
Philip E. Lapinski has a total of 6 co-authors. Here are the top co-authors by number of shared publications:
- Philip D. King
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, USA
2 shared publications - Di Chen
Department of Microbiology and Immunology, University of Michigan Medical School, Ann Arbor, MI 48109, USA
1 shared publication - Michael J. Davis
Department of Medical Pharmacology & Physiology, University of Missouri
1 shared publication Philip D. King
University of Michigan, Medical School
1 shared publication- R. Sathish Srinivasan
Cardiovascular Biology Research Program, Oklahoma Medical Research Foundation
1 shared publication - Xin Geng
Oklahoma Medical Research Foundation
1 shared publication
Latest Publications
- Open Access
RASA1-driven cellular export of collagen IV is required for the development of lymphovenous and venous valves in mice
RASA1, a negative regulator of the Ras-mitogen-activated protein kinase (MAPK) signaling pathway, is essential for the development and maintenance of lymphatic vessel (LV) valves. However, whether RASA1 is required for the development and maintenance of lymphovenous valves (LVV) and venous valves (VV) is unknown. In this study we show that induced endothelial cell (EC)-specific disruption of Rasa1 in mid-gestation mouse embryos did not affect initial specification of LVV or central VV but did affect their continued development. Similarly, switch to expression of a catalytically inactive form of RASA1 resulted in impaired LVV and VV development. Blocked development of LVV in RASA1-deficient embryos was associated with accumulation of the basement membrane protein, collagen IV, in LVV-forming EC and could be partially or completely rescued by MAPK inhibitors and drugs that promote collagen IV folding. Disruption of Rasa1 in adult mice resulted in venous hypertension and impaired VV function that was associated with loss of EC from VV leaflets. In conclusion, RASA1 functions as a negative regulator of Ras signaling in EC that is necessary for EC export of collagen IV, thus permitting the development of LVV and the development and maintenance of VV.
Open AccessRASA1-driven cellular export of collagen IV is required for the development of lymphovenous and venous valves in mice
RASA1, a negative regulator of the Ras-mitogen-activated protein kinase (MAPK) signaling pathway, is essential for the development and maintenance of lymphatic vessel (LV) valves. However, whether RASA1 is required for the development and maintenance of lymphovenous valves (LVV) and venous valves (VV) is unknown. In this study we show that induced endothelial cell (EC)-specific disruption of Rasa1 in mid-gestation mouse embryos did not affect initial specification of LVV or central VV but did affect their continued development. Similarly, switch to expression of a catalytically inactive form of RASA1 resulted in impaired LVV and VV development. Blocked development of LVV in RASA1-deficient embryos was associated with accumulation of the basement membrane protein, collagen IV, in LVV-forming EC and could be partially or completely rescued by MAPK inhibitors and drugs that promote collagen IV folding. Disruption of Rasa1 in adult mice resulted in venous hypertension and impaired VV function that was associated with loss of EC from VV leaflets. In conclusion, RASA1 functions as a negative regulator of Ras signaling in EC that is necessary for EC export of collagen IV, thus permitting the development of LVV and the development and maintenance of VV.
- 1 January 2012
- Vol. 1 (2) , 147-153
Regulation of Ras signal transduction during T cell development and activation
T cell receptor-induced activation of the Ras signaling pathway is essential for T cell development, proliferation and differentiation. Given the central role of Ras in T cell biology its activation must be tightly regulated. However, precisely how Ras activation is controlled in T cells is not completely understood. In this review, we provide a summary of the known factors and mechanisms involved in positive and negative regulation of Ras activation in the T cell lineage.
- 1 January 2012
- Vol. 1 (2) , 147-153
Regulation of Ras signal transduction during T cell development and activation
T cell receptor-induced activation of the Ras signaling pathway is essential for T cell development, proliferation and differentiation. Given the central role of Ras in T cell biology its activation must be tightly regulated. However, precisely how Ras activation is controlled in T cells is not completely understood. In this review, we provide a summary of the known factors and mechanisms involved in positive and negative regulation of Ras activation in the T cell lineage.
- 1 January 2012
- Published by Springer Nature
- p. 1601-1605
RASA1